Attached files
Exhibit
32.1
SECTION
1350 CERTIFICATION
Pursuant to the requirement set forth in Rule
13a-14(b) or Rule 15d-14(b) of the Securities Exchange Act of 1934,
as amended, and Section 1350 of Chapter 63 of Title 18 of the
United States Code (18 U.S.C. § 1350), as adopted pursuant to
Section 906 of the Sarbanes-Oxley Act of 2002, Gene S.
Cartwright, Chief Executive Officer (principal executive and
financial officer) of Guided Therapeutics Inc (the
“Company”), hereby
certifies that, to his knowledge on the date
hereof:
(a)
The Quarterly Report on Form 10-Q of the Company for the period
ended March 31, 2021 filed on the date hereof with the Securities
and Exchange Commission (the “Quarterly Report”) fully
complies with the requirements of Section 13(a) or 15(d) of the
Securities Exchange Act of 1934, as amended; and
(b)
The information contained in the Quarterly Report fairly presents,
in all material respects, the financial condition and results of
operations of the Company for the period covered by the Quarterly
Report.
This
certification shall not be deemed to be filed with the Securities
and Exchange Commission and shall not be incorporated by reference
into any filing of the Company under the Securities Act of 1933, as
amended, or the Securities Exchange Act of 1934, as amended
(whether made before or after the date of the Quarterly Report),
irrespective of any general incorporation language contained in
such filing. A signed original of this written statement required
by Section 906 has been provided to the Company and will be
retained and furnished to the Securities and Exchange Commission or
its staff upon request.
|
|
/s/ Gene S.
Cartwright
Gene S.
CartwrightChief Executive Officer
(Principal
Executive and Financial Officer)
May 20,
2021
|
|
|
|
|
|
|
|
|
|